Precigen, Inc. (PGEN) vs Tyra Biosciences, Inc. (TYRA)
- Precigen, Inc. PGEN 4.43 +4.98%
- Tyra Biosciences, Inc. TYRA 21.09 +0.96%
Precigen, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Precigen, Inc. and Tyra Biosciences, Inc. are of similar size ($1.5B and $1.4B). Tyra Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. has the higher net margin (15.6% vs 0.00%) and the higher return on invested capital (15.9% vs 0.00%). Across the 14 metrics below, Precigen, Inc. leads on 9 and Tyra Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | PGEN | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.42% | 0.00% | 68.51% |
| Operating margin | 21.43% | 0.00% | 0.00% |
| Net margin | 15.55% | 0.00% | 0.00% |
| Free cash flow margin | (47.35%) | 0.00% | 0.00% |
| Return on equity | 38.84% | (45.31%) | (51.96%) |
| Return on assets | 12.73% | (42.15%) | (46.06%) |
| Return on invested capital | 15.93% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack